Medtronic (NYSE:MDT) announced today that it exercised its option to acquire coronary artery disease (CAD) tech developer ...
Medtronic expands cath lab tools by acquiring CathWorks for $585 million, enhancing its interventional cardiology portfolio with AI technology.
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...
In its announcement, Medtronic said it plans to move forward with the CathWorks acquisition in a transaction valued at up to ...
The multimillion-dollar upgrade allows physicians to treat more complex cardiovascular cases locally, reducing the need for patients to travel outside the county for specialized procedures. Hospital ...